Groundbreaking collaborative research from the University of Michigan and the University of California San Diego has uncovered a critical biological…
Read More
Telix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger
Australia-based radiopharmaceutical leader Telix Pharmaceuticals has entered into a definitive agreement to acquire Germany’s ITM Isotope Technologies Munich in a…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
Researchers at the University of Michigan and the University of California San Diego have uncovered a critical biological mechanism that…
Read More
Eli Lilly Commits Up to $3.8 Billion to Acquire AtaiBeckley, Betting on the ‘God Molecule’ 5-MeO-DMT for Transformative Mental Healthcare
Indianapolis, IN – Pharmaceutical giant Eli Lilly has announced a definitive agreement to acquire AtaiBeckley, a clinical-stage biotechnology company focused…
Read More
Samsung Biologics to Acquire PolyPeptide Group for SFr1.46 Billion, Expanding Peptide Therapeutics and CDMO Capabilities
Samsung Biologics has announced its intent to acquire PolyPeptide Group, a leading contract development and manufacturing organization (CDMO) specializing in…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
A collaborative study conducted by researchers at the University of Michigan and the University of California San Diego has identified…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
The persistence of estrogen receptor-positive (ER+) breast cancer remains one of the most formidable challenges in modern oncology, as patients…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
This seminal research, conducted by a collaborative team from the University of Michigan and the University of California San Diego,…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
A collaborative research effort between the University of Michigan and the University of California San Diego has identified a critical…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
In a breakthrough study published in the Journal of Clinical Investigation, researchers from the University of Michigan and the University…
Read More
